FDA inspection
PAREXEL International GmbH: FDA inspection ending Nov 12, 2021
FDA inspection 1159830 · No Action Indicated (NAI) · Berlin
Key facts
| Inspection ID | 1159830 |
|---|---|
| Firm | PAREXEL International GmbH |
| FEI number | 3005921529 |
| Address | Klinikum Westend Haus 18, Spandauer Damm 130 |
| City | Berlin |
| Country | Germany |
| Fiscal year | 2022 |
| Inspection end date | Nov 12, 2021 |
| Classification | No Action Indicated (NAI) |
| Project area | Bioresearch Monitoring |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data